Cure GM1 Invests $400,000 to Advance Development of Enzyme Replacement Therapy
Cure GM1 is dedicated to investing in research, seeding new projects, and to the development…
2024 Cure GM1 Impact Report
Our summary of impact in 2024 is now available to read. Although this year was hard with…
Cure GM1 Presents to the FDA for the Inaugural Meeting of the Rare Disease Innovation Hub
This meeting was organized by the FDA and the Reagan Udall Foundation at the White…
Lingxi’s Story
Lingxi’s GM1 Story, as told by her father Her GM1 Story ” We have been…
Hampus, Julia, And Isabella’s Story
Hampus, Julia, and Isabella’s Story Their GM1 Stories “It is heartbreaking not knowing what tomorrow…
Support Continued Rare Disease Research Funding for Gene and Cell Therapies
SIGN HERE and SHARE
Sanofi Press Release: AMETHIST Trial Discontinued
We regret to inform you that in Sanofi’s quarterly press release issued today that the…
The March 2024 Cure GM1 Catalyst
2024 Cure GM1 Virtual Conference We are excited to start planning our annual conference for…
2023 Cure GM1 Impact Report – Annual Update And Beyond
Our summary of impact in 2023 is now available to read. After some time reflecting, everyone…
Iris’ Story from Her Brother’s Perspective
As told by Iris’ brother. How has GM1 gangliosidosis affected your life? GM1 Gangliosidosis is…